DNA Biomed (Israel) Technical Analysis

DNA Stock  ILS 89.60  1.00  1.10%   
As of the 19th of April, DNA Biomed owns the Coefficient Of Variation of 720.98, downside deviation of 3.14, and Market Risk Adjusted Performance of (0.31). DNA Biomed Solns technical analysis allows you to utilize past data patterns in order to determine a pattern that computes the direction of the firm's future prices. Strictly speaking, you can use this information to find out if the firm will indeed mirror its model of historical prices and volume patterns, or the prices will eventually revert. We were able to analyze nineteen technical drivers for DNA Biomed, which can be compared to its peers in the sector. Please confirm DNA Biomed Solns jensen alpha, semi variance, and the relationship between the standard deviation and value at risk to decide if DNA Biomed Solns is priced favorably, providing market reflects its prevailing price of 89.6 per share.

DNA Biomed Momentum Analysis

Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as DNA, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to DNA
  
DNA Biomed's Momentum analyses are specifically helpful, as they help investors time the market using mark points where the market can reverse. The reversal spots are usually identified through divergence between price movement and momentum.
DNA Biomed technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of DNA Biomed technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of DNA Biomed trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

DNA Biomed Solns Technical Analysis

Indicator
Time Period
Execute Indicator
The output start index for this execution was three with a total number of output elements of fifty-eight. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of DNA Biomed Solns volatility. High ATR values indicate high volatility, and low values indicate low volatility.

DNA Biomed Solns Trend Analysis

Use this graph to draw trend lines for DNA Biomed Solns. You can use it to identify possible trend reversals for DNA Biomed as well as other signals and approximate when it will take place. Remember, you need at least two touches of the trend line with actual DNA Biomed price movement. To start drawing, click on the pencil icon on top-right. To remove the trend, use eraser icon.

DNA Biomed Best Fit Change Line

The following chart estimates an ordinary least squares regression model for DNA Biomed Solns applied against its price change over selected period. The best fit line has a slop of   0.32  , which means DNA Biomed Solns will continue generating value for investors. It has 122 observation points and a regression sum of squares at 3903.81, which is the sum of squared deviations for the predicted DNA Biomed price change compared to its average price change.

About DNA Biomed Technical Analysis

The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of DNA Biomed Solns on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of DNA Biomed Solns based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on DNA Biomed Solns price pattern first instead of the macroeconomic environment surrounding DNA Biomed Solns. By analyzing DNA Biomed's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of DNA Biomed's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to DNA Biomed specific price patterns or momentum indicators. Please read more on our technical analysis page.

DNA Biomed April 19, 2024 Technical Indicators

Most technical analysis of DNA help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for DNA from various momentum indicators to cycle indicators. When you analyze DNA charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in DNA Biomed Solns. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors.
Note that the DNA Biomed Solns information on this page should be used as a complementary analysis to other DNA Biomed's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Transaction History module to view history of all your transactions and understand their impact on performance.

Complementary Tools for DNA Stock analysis

When running DNA Biomed's price analysis, check to measure DNA Biomed's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy DNA Biomed is operating at the current time. Most of DNA Biomed's value examination focuses on studying past and present price action to predict the probability of DNA Biomed's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move DNA Biomed's price. Additionally, you may evaluate how the addition of DNA Biomed to your portfolios can decrease your overall portfolio volatility.
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Commodity Directory
Find actively traded commodities issued by global exchanges
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Equity Valuation
Check real value of public entities based on technical and fundamental data
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Please note, there is a significant difference between DNA Biomed's value and its price as these two are different measures arrived at by different means. Investors typically determine if DNA Biomed is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, DNA Biomed's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.